Women get HIV, the virus that causes AIDS, primarily through vaginal sex with an infected partner. In the United States, 83% of new HIV infections among women are attributed to heterosexual contact, making it the dominant route by a wide margin. Sharing needles accounts for most of the rest. Understanding how the virus enters the body, why women face higher biological risk than men during sex, and what actually prevents transmission can help you protect yourself.
Vaginal Sex Is the Primary Route
During vaginal intercourse with an HIV-positive partner who is not on treatment, the estimated risk of transmission is about 1 in 1,250 per act for the receptive partner (the woman). That number sounds low for a single encounter, but risk accumulates with repeated exposure, and several common factors can multiply it dramatically.
HIV is carried in semen, pre-seminal fluid, and blood. During vaginal sex, the virus can enter through the mucous membranes lining the vagina and cervix. These tissues are thin, moist, and rich in the immune cells that HIV specifically targets. The cervix in particular has a large surface area of delicate tissue that the virus can penetrate, which is one reason receptive vaginal sex carries higher risk than insertive vaginal sex.
Other sexual routes matter too. Anal sex carries a significantly higher per-act risk than vaginal sex because rectal tissue is even thinner and more prone to small tears. Oral sex poses a much lower risk, though it increases if there are mouth sores, bleeding gums, or genital sores involved.
Why Women Are More Biologically Vulnerable
Women face a higher risk of contracting HIV from a male partner than the reverse during vaginal sex, and the reasons are largely anatomical. The vaginal canal and cervix expose a large area of mucous membrane to an infected partner’s fluids, and semen can remain in contact with that tissue for hours after sex.
The vaginal environment itself plays a role. A healthy vagina is dominated by beneficial bacteria that produce lactic acid, keeping the pH low. This acidic environment can actually inactivate HIV. But when the balance of vaginal bacteria shifts, as happens with bacterial vaginosis (a very common condition), that protective acidity drops. Women with bacterial vaginosis have consistently shown higher rates of HIV acquisition. The disrupted bacterial environment triggers inflammation, which recruits more of the exact immune cells HIV targets to the vaginal and cervical tissue. In one study, women with the most disrupted vaginal bacteria had 17 times more activated HIV target cells on cervical tissue compared to women with a healthy bacterial balance.
Having another sexually transmitted infection also raises risk. STIs like herpes, syphilis, gonorrhea, and chlamydia can cause sores, breaks in the skin, or chronic inflammation in genital tissue. All of these give HIV easier access to the bloodstream.
Sharing Needles and Other Non-Sexual Routes
Injection drug use accounts for about 3% of new HIV infections among women in the U.S., roughly 1,000 cases per year. Sharing needles, syringes, or other equipment used to prepare or inject drugs allows infected blood to pass directly from one person to another. Even a small amount of blood left in a needle is enough.
Less common routes include occupational exposure (such as an accidental needlestick in a healthcare setting) and, rarely, blood transfusions in countries without rigorous screening. In the U.S. and most high-income countries, the blood supply has been screened for HIV since 1985, making transfusion-related transmission extremely rare.
Transmission During Pregnancy and Breastfeeding
A mother living with HIV can pass the virus to her child during pregnancy, labor, delivery, or breastfeeding. Without any treatment, the transmission rate ranges from 15% to 45%. With proper antiretroviral treatment throughout pregnancy and delivery, that rate drops to below 1% in most settings. This is one of the major success stories in HIV prevention, and routine prenatal HIV testing is standard in most countries for exactly this reason.
What Does Not Transmit HIV
HIV cannot spread through casual contact. Hugging, kissing, sharing food or drinks, toilet seats, swimming pools, and insect bites do not transmit the virus. HIV dies quickly outside the body and cannot survive in saliva, sweat, or tears in concentrations high enough to infect another person. The virus requires direct access to the bloodstream or mucous membranes through specific body fluids: blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, and breast milk.
How Prevention Works for Women
Condoms remain one of the most effective barriers against HIV when used consistently. Male condoms reduce the risk of HIV transmission by a substantial margin, and internal (female) condoms offer a similar level of protection while giving women more direct control.
PrEP, a daily pill taken by HIV-negative people, is highly effective at preventing infection. For vaginal sex, PrEP reaches maximum protection after about 7 daily doses, according to World Health Organization guidelines. The CDC advises about 21 days of daily use for full protection in vaginal tissue. The difference reflects varying interpretations of the pharmacokinetic data, but the key point is that PrEP needs to be taken consistently. Unlike rectal tissue, which absorbs the medication faster, vaginal tissue takes longer to build up protective drug concentrations.
Perhaps the most powerful prevention fact: a person living with HIV who takes treatment and maintains an undetectable viral load has zero risk of transmitting the virus to sexual partners. This principle, known as Undetectable = Untransmittable, is backed by large studies with no documented cases of transmission from a partner with sustained viral suppression.
Testing and the Window Period
If you think you may have been exposed to HIV, timing matters for testing. The most common modern tests (called fourth-generation tests) look for both HIV antibodies and a piece of the virus itself. These tests detect 99% of infections by 45 days after exposure. Most UK and U.S. guidelines recommend testing at six weeks post-exposure for a reliable result, with a follow-up at three months if the initial test is negative and risk was significant.
Rapid tests and home tests that detect only antibodies may take longer to turn positive, sometimes up to 90 days. If you test too early during the “window period,” you could get a negative result even if you’ve been infected. Early testing is still worthwhile because it can sometimes catch infection sooner, but a negative result during the window period isn’t definitive.
From HIV to AIDS
HIV and AIDS are not the same thing. HIV is the virus; AIDS is the most advanced stage of HIV infection, when the immune system is severely damaged. Without treatment, HIV typically progresses to AIDS within 8 to 10 years, though this varies. With modern antiretroviral treatment, most people living with HIV never develop AIDS. Treatment keeps the virus suppressed, the immune system intact, and life expectancy close to normal. The critical factor is getting tested and starting treatment early.